in Health

Myasthenia Gravis Complement Inhibitor Meets Primary Endpoint in Phase III Trial

Source link : https://newshealth.biz/health-news/myasthenia-gravis-complement-inhibitor-meets-primary-endpoint-in-phase-iii-trial/

(MedPage Today) — SAN FRANCISCO — Investigational gefurulimab met its primary efficacy endpoint in adults with anti-acetylcholine receptor (AChR) antibody-positive generalized myasthenia gravis (MG), topline data from the phase III PREVAIL… Source link : https://www.medpagetoday.com/meetingcoverage/aanem/118297 Author : Publish date : 2025-11-03 22:43:00 Copyright for syndicated content belongs to the linked Source.

The post Myasthenia Gravis Complement Inhibitor Meets Primary Endpoint in Phase III Trial first appeared on News Health.

—-

Author : News Health

Publish date : 2025-11-03 22:43:00

Copyright for syndicated content belongs to the linked Source.

—-

1 – 2 – 3 – 4 – 5 – 6 – 7 – 8

Health

German company announces its opening U.S. headquarters in The Woodlands – The Courier of Montgomery County

Here are some engaging, source-free rewrites you can use – pick a tone and I can refine further: 1. “JJ Redick Calls Out Lakers’ Biggest Problem After Win Over Heat” 2. “After Beating the Heat, JJ Redick Names What’s Holding the Lakers Back” 3. “JJ R